Deficiency in calcium-binding protein S100A4 impairs the adjuvant action of cholera toxin

Jia Bin Sun, Jan Holmgren, Maximilian Larena, Manuela Terrinoni, Yu Fang, Anne R. Bresnick, Zou Xiang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The calcium-binding protein S100A4 has been described to promote pathological inflammation in experimental autoimmune and inflammatory disorders and in allergy and to contribute to antigen presentation and antibody response after parenteral immunization with an alum-adjuvanted antigen. In this study, we extend these findings by demonstrating that mice lacking S100A4 have a defective humoral and cellular immune response to mucosal (sublingual) immunization with a model protein antigen [ovalbumin (OVA)] given together with the strong mucosal adjuvant cholera toxin (CT), and that this impairment is due to defective adjuvant-stimulated antigen presentation by antigen-presenting cells. In comparison to wild-type (WT) mice, mice genetically lacking S100A4 had reduced humoral and cellular immune responses after immunization with OVA plus CT, including a complete lack of detectable germinal center reaction. Further, when stimulated in vitro with OVA plus CT, S100A4-/- dendritic cells (DCs) showed impaired responses in several CT-stimulated immune regulatory molecules including the co-stimulatory molecule CD86, inflammasome-associated caspase-1 and IL-1ß. Coculture of OVA-specific OT-II T cells with S100A4-/- DCs that had been pulse incubated with OVA plus CT resulted in impaired OT-II T cell proliferation and reduced production of Th1, Th2, and Th17 cytokines compared to similar cocultures with WT DCs. In accordance with these findings, transfection of WT DCs with S100A4-targeting small interfering RNA (siRNA) but not mock-siRNA resulted in significant reductions in the expression of caspase-1 and IL-1ß as well as CD86 in response to CT. Importantly, also engraftment of WT DCs into S100A4-/- mice effectively restored the immune response to immunization in the recipients. In conclusion, our results demonstrate that deficiency in S100A4 has a strong impact on the development of both humoral and cellular immunity after mucosal immunization using CT as adjuvant.

Original languageEnglish (US)
Article number1119
JournalFrontiers in Immunology
Volume8
Issue numberSEP
DOIs
StatePublished - Sep 11 2017

Fingerprint

Calcium-Binding Proteins
Cholera Toxin
Ovalbumin
Dendritic Cells
Immunization
Humoral Immunity
Cellular Immunity
Caspase 1
Antigen Presentation
Coculture Techniques
Interleukin-1
Small Interfering RNA
Inflammasomes
T-Lymphocytes
Antigens
Germinal Center
Antigen-Presenting Cells
Antibody Formation
Transfection
Hypersensitivity

Keywords

  • Adjuvant
  • Cholera toxin
  • Dendritic cells
  • Germinal center
  • S100A4

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Deficiency in calcium-binding protein S100A4 impairs the adjuvant action of cholera toxin. / Sun, Jia Bin; Holmgren, Jan; Larena, Maximilian; Terrinoni, Manuela; Fang, Yu; Bresnick, Anne R.; Xiang, Zou.

In: Frontiers in Immunology, Vol. 8, No. SEP, 1119, 11.09.2017.

Research output: Contribution to journalArticle

Sun, Jia Bin ; Holmgren, Jan ; Larena, Maximilian ; Terrinoni, Manuela ; Fang, Yu ; Bresnick, Anne R. ; Xiang, Zou. / Deficiency in calcium-binding protein S100A4 impairs the adjuvant action of cholera toxin. In: Frontiers in Immunology. 2017 ; Vol. 8, No. SEP.
@article{b14290ecaf804d6da94013be104d94b6,
title = "Deficiency in calcium-binding protein S100A4 impairs the adjuvant action of cholera toxin",
abstract = "The calcium-binding protein S100A4 has been described to promote pathological inflammation in experimental autoimmune and inflammatory disorders and in allergy and to contribute to antigen presentation and antibody response after parenteral immunization with an alum-adjuvanted antigen. In this study, we extend these findings by demonstrating that mice lacking S100A4 have a defective humoral and cellular immune response to mucosal (sublingual) immunization with a model protein antigen [ovalbumin (OVA)] given together with the strong mucosal adjuvant cholera toxin (CT), and that this impairment is due to defective adjuvant-stimulated antigen presentation by antigen-presenting cells. In comparison to wild-type (WT) mice, mice genetically lacking S100A4 had reduced humoral and cellular immune responses after immunization with OVA plus CT, including a complete lack of detectable germinal center reaction. Further, when stimulated in vitro with OVA plus CT, S100A4-/- dendritic cells (DCs) showed impaired responses in several CT-stimulated immune regulatory molecules including the co-stimulatory molecule CD86, inflammasome-associated caspase-1 and IL-1{\ss}. Coculture of OVA-specific OT-II T cells with S100A4-/- DCs that had been pulse incubated with OVA plus CT resulted in impaired OT-II T cell proliferation and reduced production of Th1, Th2, and Th17 cytokines compared to similar cocultures with WT DCs. In accordance with these findings, transfection of WT DCs with S100A4-targeting small interfering RNA (siRNA) but not mock-siRNA resulted in significant reductions in the expression of caspase-1 and IL-1{\ss} as well as CD86 in response to CT. Importantly, also engraftment of WT DCs into S100A4-/- mice effectively restored the immune response to immunization in the recipients. In conclusion, our results demonstrate that deficiency in S100A4 has a strong impact on the development of both humoral and cellular immunity after mucosal immunization using CT as adjuvant.",
keywords = "Adjuvant, Cholera toxin, Dendritic cells, Germinal center, S100A4",
author = "Sun, {Jia Bin} and Jan Holmgren and Maximilian Larena and Manuela Terrinoni and Yu Fang and Bresnick, {Anne R.} and Zou Xiang",
year = "2017",
month = "9",
day = "11",
doi = "10.3389/fimmu.2017.01119",
language = "English (US)",
volume = "8",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "SEP",

}

TY - JOUR

T1 - Deficiency in calcium-binding protein S100A4 impairs the adjuvant action of cholera toxin

AU - Sun, Jia Bin

AU - Holmgren, Jan

AU - Larena, Maximilian

AU - Terrinoni, Manuela

AU - Fang, Yu

AU - Bresnick, Anne R.

AU - Xiang, Zou

PY - 2017/9/11

Y1 - 2017/9/11

N2 - The calcium-binding protein S100A4 has been described to promote pathological inflammation in experimental autoimmune and inflammatory disorders and in allergy and to contribute to antigen presentation and antibody response after parenteral immunization with an alum-adjuvanted antigen. In this study, we extend these findings by demonstrating that mice lacking S100A4 have a defective humoral and cellular immune response to mucosal (sublingual) immunization with a model protein antigen [ovalbumin (OVA)] given together with the strong mucosal adjuvant cholera toxin (CT), and that this impairment is due to defective adjuvant-stimulated antigen presentation by antigen-presenting cells. In comparison to wild-type (WT) mice, mice genetically lacking S100A4 had reduced humoral and cellular immune responses after immunization with OVA plus CT, including a complete lack of detectable germinal center reaction. Further, when stimulated in vitro with OVA plus CT, S100A4-/- dendritic cells (DCs) showed impaired responses in several CT-stimulated immune regulatory molecules including the co-stimulatory molecule CD86, inflammasome-associated caspase-1 and IL-1ß. Coculture of OVA-specific OT-II T cells with S100A4-/- DCs that had been pulse incubated with OVA plus CT resulted in impaired OT-II T cell proliferation and reduced production of Th1, Th2, and Th17 cytokines compared to similar cocultures with WT DCs. In accordance with these findings, transfection of WT DCs with S100A4-targeting small interfering RNA (siRNA) but not mock-siRNA resulted in significant reductions in the expression of caspase-1 and IL-1ß as well as CD86 in response to CT. Importantly, also engraftment of WT DCs into S100A4-/- mice effectively restored the immune response to immunization in the recipients. In conclusion, our results demonstrate that deficiency in S100A4 has a strong impact on the development of both humoral and cellular immunity after mucosal immunization using CT as adjuvant.

AB - The calcium-binding protein S100A4 has been described to promote pathological inflammation in experimental autoimmune and inflammatory disorders and in allergy and to contribute to antigen presentation and antibody response after parenteral immunization with an alum-adjuvanted antigen. In this study, we extend these findings by demonstrating that mice lacking S100A4 have a defective humoral and cellular immune response to mucosal (sublingual) immunization with a model protein antigen [ovalbumin (OVA)] given together with the strong mucosal adjuvant cholera toxin (CT), and that this impairment is due to defective adjuvant-stimulated antigen presentation by antigen-presenting cells. In comparison to wild-type (WT) mice, mice genetically lacking S100A4 had reduced humoral and cellular immune responses after immunization with OVA plus CT, including a complete lack of detectable germinal center reaction. Further, when stimulated in vitro with OVA plus CT, S100A4-/- dendritic cells (DCs) showed impaired responses in several CT-stimulated immune regulatory molecules including the co-stimulatory molecule CD86, inflammasome-associated caspase-1 and IL-1ß. Coculture of OVA-specific OT-II T cells with S100A4-/- DCs that had been pulse incubated with OVA plus CT resulted in impaired OT-II T cell proliferation and reduced production of Th1, Th2, and Th17 cytokines compared to similar cocultures with WT DCs. In accordance with these findings, transfection of WT DCs with S100A4-targeting small interfering RNA (siRNA) but not mock-siRNA resulted in significant reductions in the expression of caspase-1 and IL-1ß as well as CD86 in response to CT. Importantly, also engraftment of WT DCs into S100A4-/- mice effectively restored the immune response to immunization in the recipients. In conclusion, our results demonstrate that deficiency in S100A4 has a strong impact on the development of both humoral and cellular immunity after mucosal immunization using CT as adjuvant.

KW - Adjuvant

KW - Cholera toxin

KW - Dendritic cells

KW - Germinal center

KW - S100A4

UR - http://www.scopus.com/inward/record.url?scp=85029668638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029668638&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2017.01119

DO - 10.3389/fimmu.2017.01119

M3 - Article

VL - 8

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - SEP

M1 - 1119

ER -